Results of an open label randomized phase II trial of CV9104, an mRNA-based multivalent cancer immunotherapy in patients (pts) with intermediate or high risk localized prostate cancer (PC) undergoing radical prostatectomy (RPE)

Document type:: Meeting Abstract
Author(s):: Stenzl, A; Feyerabend, S; Kubler, H; Retz, M; Grullich, C; Hipp, M; Klinkhardt, U; Hong, HS; Doener, F; Koch, SD; Scholl, M; Brutlach, S; Schroeder, A; Seibel, T; Halama, N; Schonborn-Kellenberger, O; Fotin-Mleczek, M; Gnad-Vogt, U
Title:: Results of an open label randomized phase II trial of CV9104, an mRNA-based multivalent cancer immunotherapy in patients (pts) with intermediate or high risk localized prostate cancer (PC) undergoing radical prostatectomy (RPE)
Journal title abbreviation:: Ann Oncol
Year:: 2017
Journal volume:: 28 5
Pages contribution:: -
Language:: eng
Print-ISSN:: 0923-7534
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: